of Week Home
6 October 2011 – Case of the Week #219
This email is only sent to subscribers. To subscribe or unsubscribe to this or our other email lists, click here.
All cases are archived on our website. To view them sorted by number, diagnosis or category, visit our Home Page and click on the Case of the Week button on the left hand side.
Thanks to Dr. David Cohen, Herzliyah Medical Center, Israel, for contributing this case. To contribute a Case of the Week, follow the guidelines on our Case of the Week page.
(1) We are looking for pathologists with expertise in the topic to write a 250 word article on "What's New" for these future Feature Pages: Consumable Lab Products (Nov11), Grossing workstations / lab furniture (Dec11), Billing / consulting / management (Jan12), Microscopes / slide imaging (Feb12), for $50 per article. If interested, email Dr. Pernick at email@example.com.
(2) The ASCP published their Fellowship and Job Market survey, click here.
(3) To encourage a wider display of pathology related books on our Books pages, we are pleased to announce a new low price of $100 to post any pathology related book, with a link to the publisher. We will post the book on the appropriate books page, as well as on the New Books and Author pages. We will also include it in our Website News / New Books email. There is a 20% discount for posting 3 or more books. There is no charge to post a book which is sold through Amazon.com
Case of the Week #219
A 76 year old man with an unknown clinical history had an irregular process on the posterior bladder wall, which was biopsied.
What is your diagnosis?
High grade urothelial carcinoma - plasmacytoid and lymphoma-like variant
Immunostains were performed:
Left to right: EMA, CD20, CD38, CD138
The tumor consisted of a dyscohesive pattern of urothelial tumor cells resembling plasma cells, due to abundant glassy eosinophilic cytoplasm and eccentric nuclei. No binucleated forms were present. In some areas, the tumor resembled a low grade lymphoma. Obvious areas of high grade urothelial carcinoma were also present in other sections.
Plasmacytoid variant of urothelial carcinoma is part of the WHO/ISUP classification of tumors of the urinary tract. These tumors are rare, and tend to present at advanced stage with a poor prognosis (Int J Cancer 2011;129:346). Tumors are strongly positive for epithelial markers (cytokeration, EMA) and GATA-3 (Hum Pathol 2011;42:1149), and are usually negative for CD38 and light chains, markers for plasma cells. There often is immunoreactivity for CD138 (Hum Pathol 2009;40:1023, Am J Surg Pathol 2009;33:417).
Differential diagnosis includes chronic cystitis and plasmacytoma, particularly a problem in limited biopsies.
Treatment consists of surgery plus chemotherapy (Int J Clin Oncol 2011 Jul 7 [Epub ahead of print]).
Nat Pernick, M.D., President
30100 Telegraph Road, Suite 408
Bingham Farms, Michigan (USA) 48025
Alternate email: NatPernick@gmail.com